Grimes & Company’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,142
| Closed | -$10.6K | – | 399 |
|
|
2024
Q3 | $10.6K | Hold |
15,142
| – | – | ﹤0.01% | 366 |
|
|
2024
Q2 | $15.1K | Buy |
15,142
+1,028
| +7% | +$1.03K | ﹤0.01% | 347 |
|
|
2024
Q1 | $33.5K | Buy |
14,114
+458
| +3% | +$1.09K | ﹤0.01% | 339 |
|
|
2023
Q4 | $30.7K | Sell |
13,656
-330
| -2% | -$743 | ﹤0.01% | 326 |
|
|
2023
Q3 | $29.7K | Buy |
13,986
+364
| +3% | +$772 | ﹤0.01% | 296 |
|
|
2023
Q2 | $42.1K | Hold |
13,622
| – | – | ﹤0.01% | 302 |
|
|
2023
Q1 | $73.3K | Buy |
13,622
+2,766
| +25% | +$14.9K | ﹤0.01% | 288 |
|
|
2022
Q4 | $72.2K | Buy |
+10,856
| New | +$72.2K | ﹤0.01% | 280 |
|